GSK just offered Adaptimmune $350 mil partnership offer. Oncs could be next. Keep your hope alive. Don't give up.
manipulation of the share price sux baLLs, but then again, the inevitable of progress moves forward (aka 3-4 bucks a share) and is around the corner..no manipulating that.
Just remember 3 or 4 bucks a share will not happen without partnership or some type of special designation from the FDA.Maybe MCC data will be the real catalyst for this stock?
"Don't give up?" Who was giving up? What in the world are you talking about? Have a shot of tequila and calm down.